120 related articles for article (PubMed ID: 36525567)
1. Evaluating reduction in medical costs associated with pharmacists' presence in the emergency department using a novel cost avoidance framework.
Poremba M; Champa K; Reichert E
Am J Health Syst Pharm; 2023 Aug; 80(Suppl 3):S111-S118. PubMed ID: 36525567
[TBL] [Abstract][Full Text] [Related]
2. PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study.
Rech MA; Adams W; Smetana KS; Gurnani PK; Van Berkel Patel MA; Peppard WJ; Hammond DA; Flannery AH
Crit Care Explor; 2021 Apr; 3(4):e0406. PubMed ID: 33912836
[TBL] [Abstract][Full Text] [Related]
3. Emergency medicine pharmacist interventions reducing exposure to costs (EMPIRE-C).
Dietrich SK; Bushong BT; Schneider-Smith EA; Mixon MA
Am J Emerg Med; 2022 Apr; 54():178-183. PubMed ID: 35158260
[TBL] [Abstract][Full Text] [Related]
4. Cost-avoidance associated with implementation of an overnight emergency medicine pharmacist at a Level I Trauma, Comprehensive Stroke Center.
Nguyen MH; Gordon K; Reachi B; Bair J; Chauv S; Fontaine GV
Am J Emerg Med; 2024 May; 82():63-67. PubMed ID: 38805940
[TBL] [Abstract][Full Text] [Related]
5. Documentation of pharmacists' interventions in an emergency department and associated cost avoidance.
Lada P; Delgado G
Am J Health Syst Pharm; 2007 Jan; 64(1):63-8. PubMed ID: 17189582
[TBL] [Abstract][Full Text] [Related]
6. Implementation of pharmacist targeted discharge prescription review in an emergency department.
Lineberry E; Rozycki E; Jordan TA; Mellett J; North AM
Am J Emerg Med; 2021 Oct; 48():288-294. PubMed ID: 34023809
[TBL] [Abstract][Full Text] [Related]
7. PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.
Rech MA; Gurnani PK; Peppard WJ; Smetana KS; Van Berkel MA; Hammond DA; Flannery AH
Crit Care Explor; 2021 Dec; 3(12):e0594. PubMed ID: 34913039
[TBL] [Abstract][Full Text] [Related]
8. Scoping Review of Interventions Associated with Cost Avoidance Able to Be Performed in the Intensive Care Unit and Emergency Department.
Hammond DA; Gurnani PK; Flannery AH; Smetana KS; Westrick JC; Lat I; Rech MA
Pharmacotherapy; 2019 Mar; 39(3):215-231. PubMed ID: 30664269
[TBL] [Abstract][Full Text] [Related]
9. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
Chan LEJ; Soong JL; Lie SA
Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
[TBL] [Abstract][Full Text] [Related]
10. Integration of a clinical pharmacist into a Canadian, urban emergency department: a prospective observational study.
Dryden L; Dewhurst NF
Int J Pharm Pract; 2019 Apr; 27(2):175-179. PubMed ID: 30079985
[TBL] [Abstract][Full Text] [Related]
11. Development of an emergency medicine pharmacy intensity score tool.
Weant KA; Acquisto NM; Doyno CR; Gregory H; Rech MA; Schlobohm CJ; Smith AP; Won KJ
Am J Health Syst Pharm; 2023 Feb; 80(4):215-221. PubMed ID: 36322132
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical interventions in the emergency department: cost-effectiveness and cost-benefit analysis.
Miarons M; Marín S; Amenós I; Campins L; Rovira M; Daza M
Eur J Hosp Pharm; 2021 May; 28(3):133-138. PubMed ID: 35049519
[TBL] [Abstract][Full Text] [Related]
13. Impact of oral chemotherapy pharmacists on cost avoidance of oral oncolytics in an integrated health system.
Nguyen AL
J Oncol Pharm Pract; 2023 Sep; 29(6):1369-1373. PubMed ID: 36002947
[TBL] [Abstract][Full Text] [Related]
14. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
15. Evaluating and classifying pharmacists' quality interventions in the emergency department.
Abu-Ramaileh AM; Shane R; Churchill W; Steffenhagen A; Patka J; Rothschild JM
Am J Health Syst Pharm; 2011 Dec; 68(23):2271-5. PubMed ID: 22095817
[TBL] [Abstract][Full Text] [Related]
16. Description of telepharmacy services by emergency medicine pharmacists.
Manuel FC; Wieruszewski ED; Brown CS; Russi CS; Mattson AE
Am J Health Syst Pharm; 2022 May; 79(11):873-880. PubMed ID: 35084439
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics: PHARM-PEDS Study.
Kiskaddon AL; Smith MM; Gilliland F; Rech MA
Crit Care Explor; 2023 Oct; 5(10):e0980. PubMed ID: 37811129
[TBL] [Abstract][Full Text] [Related]
18. Discharge prescription optimization by emergency medicine pharmacists in an academic emergency department in the United States.
Castillo J; Campbell MJ; Sokn E; Spinner M; Lam SW; Meldon S; Podolsky S
Int J Clin Pharm; 2021 Jun; 43(3):673-680. PubMed ID: 33124677
[TBL] [Abstract][Full Text] [Related]
19. The Impacts of Clinical Pharmacists' Interventions on Clinical Significance and Cost Avoidance in a Tertiary Care University Hospital in Oman: A Retrospective Analysis.
Al-Maqbali JS; Taqi A; Al-Ajmi S; Al-Hamadani B; Al-Hamadani F; Bahram F; Al-Balushi K; Gamal S; Al-Lawati E; Al Siyabi B; Al Siyabi E; Al-Sharji N; Al-Zakwani I
Pharmacy (Basel); 2022 Oct; 10(5):. PubMed ID: 36287448
[TBL] [Abstract][Full Text] [Related]
20. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
